Driehaus Capital Management’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Driehaus Capital Management's GPCR Position: Q3 2026 in Review
Driehaus Capital Management reduced its Structure Therapeutics (GPCR) stake by 48% in Q3 2026, selling an estimated $35.2M and leaving 803,818 shares worth $25.1M. The position accounts for 0.17% of the portfolio, ranked #174.
Driehaus Capital Management first reported a position in GPCR in Q1 2023 and has held it in 15 quarters since. The position peaked at $120M in Q3 2023. 170 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Driehaus Capital Management held 803,818 shares of Structure Therapeutics worth $25.1M as of Q3 2026.
- Driehaus Capital Management sold 749,401 Structure Therapeutics shares in Q3 2026, an estimated $35.2M.
- Structure Therapeutics made up 0.17% of Driehaus Capital Management's portfolio in Q3 2026, its #174 holding.
- Driehaus Capital Management first reported a position in Structure Therapeutics in Q1 2023 and has held it in 15 quarters since.
- Driehaus Capital Management's Structure Therapeutics position peaked at $120M in Q3 2023.
- 170 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Driehaus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.